3.Surveillance of antimicrobial susceptibility of urinary pathogens in a tertiary care hospital.
Subhash C ARYA ; Nirmala AGARWAL ; Shekhar AGARWAL
Singapore medical journal 2007;48(3):270-author reply 271
		                        		
		                        		
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Ceftazidime
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Cross Infection
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			microbiology
		                        			;
		                        		
		                        			Escherichia coli Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Gentamicins
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			India
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Klebsiella Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Microbial Sensitivity Tests
		                        			;
		                        		
		                        			Proteus Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Pseudomonas Infections
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Urinary Tract Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			epidemiology
		                        			;
		                        		
		                        			microbiology
		                        			
		                        		
		                        	
4.Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Subhash C ARYA ; Nirmala AGARWAL ; Bhavani S SOLANKI ; Shekhar AGARWAL
Singapore medical journal 2007;48(6):600-601
		                        		
		                        		
		                        		
		                        			Anti-Bacterial Agents
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Cephalosporins
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Drug Resistance, Multiple, Bacterial
		                        			;
		                        		
		                        			Escherichia coli
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Escherichia coli Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Hospitals, Urban
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			India
		                        			;
		                        		
		                        			Intensive Care Units
		                        			;
		                        		
		                        			Klebsiella Infections
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Klebsiella pneumoniae
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Microbial Sensitivity Tests
		                        			;
		                        		
		                        			Penicillanic Acid
		                        			;
		                        		
		                        			analogs & derivatives
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Piperacillin
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Sepsis
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			Thienamycins
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			beta-Lactamases
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			drug effects
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail